Comparison of bed-up-head-elevated intubation position with Glidescope assisted tracheal intubation: a randomised, controlled, non-inferiority trial by Samuel Ern Hung, Tsan et al.
Methods: With institutional and heads of departments’
approval, an email invitation was sent to consultants and
trainees in Western Australia. The email contained a link
to an on-line survey questionnaire containing 18 questions
and one box for written comments.
Results: At the time of abstract submission, 156
responses (16% trainees, 71% male) were received. Most
respondents (62%) thought that RDT did not infringe on
employees’ rights and 85% felt that healthcare organisa-
tions have the right to require such testing when an
employee is suspected of using alcohol or drugs before
commencing work. Fifty-two percent felt that RDTwould
improve patient safety but only 44% thought that it would
improve staff safety. Most (90%) respondents thought that
RDTwould not influence their personal use of alcohol and
drugs. Sixty-three percent supported RDTof anaesthetists
and there were similar levels of support for RDT of sur-
geons (62%), anaesthesia assistants (66%), PACU staff
(65%), operating theatre nurses (64%) and hospital phar-
macists (66%). If RDT was introduced, respondents dif-
fered in their preferred frequency of testing (26% twice
a year, 27% unsure, 9% monthly). RDT of road users by
police was supported by 96% of respondents and there
were widely differing views on the current system of drug
security, distribution or disposal being a deterrent or
reducing drug diversion. Several respondents would sup-
port a pilot program of RDT so long as all workers in the
anaesthesia workplace were included and others sug-
gested a targeted program of RDT for those workers
who had been observed to have a decline in their
performance.
Discussion: The introduction of RDT into the anaesthe-
sia workplace has been discussed elsewhere.3 Our survey
found majority support for such programs in our hospitals
as long as the testing extended to others who work along-
side us. There was disagreement whether RDT would
enhance patient or staff safety; and the preferred frequen-
cy of testing staff if it was to be introduced. There was high
support for police testing of road users and uncertainty
about the current systems for drug security.
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Proper positioning during intubation is critical in order to
increase the likelihood of success. The bed-up-head-
elevated (BUHE) intubation position has been shown to
improve laryngeal view, reduce airway complications and
prolong safe apneic time during intubation. Concurrently
in the last decade, there has been an exponential increase
in the use of video laryngoscopy (VL) devices, especially
for difficult airway patients, as it has been shown to
improve laryngeal exposure. The use of VL will increase,
and may replace traditional laryngoscopy one day. In this
study, we sought to determine if the BUHE intubation
position is non-inferior to Glidescope-assisted intubation
with regards to laryngeal exposure. In addition, we aimed
to determine the differences in time required for intuba-
tion (TRI) in the two groups.
Methods: A total of 138 ASA 1 to 3 adults planned for
elective surgeries were recruited into the study. Patients
with Body Mass Index more than 35 kgm-3 were excluded,
as were patients who required rapid sequence intubation
or awake fibreoptic intubation. Randomisation was per-
formed in blocks of six using computer generated sequen-
ces, equally allocating patients into two groups using
sealed envelopes. Group A patients (n¼ 69) were intu-
bated in the BUHE position (end point being the horizon-
tal alignment of the external auditory meatus to the ster-
nal angle), while Group B patients (n¼ 69) were intubated
using Glidescope laryngoscopy. In both groups, baseline
laryngoscopy was first performed in the sniffing position
using Macintosh laryngoscope. Laryngeal exposure was
measured using Percentage of Glottic Opening (POGO)
score, and non-inferiority will be declared if the mean
POGO scores in both groups do not differ by 15%
for a one sided 97.5% confidence interval. The TRI was
measured from beginning of laryngoscopy to the first
detected end tidal carbon dioxide and assessed for supe-
riority, as were the secondary outcomes (Number of intu-
bation attempts, use of airway adjuncts, effort during
laryngoscopy and complications during intubation).
Results: Mean POGO score in Group A was 80.14 þ/
22.03%, while in Group B it was 86.45 þ/ 18.83%
(p¼ 0.073), with a mean difference of 6.3% (95% confi-
dence interval 13.2%, 0.6%). In both groups, there was a
significant improvement in mean POGO scores (Group A
25.8 þ/ 4.7%, Group B 30.7 þ/ 6.8%) when compared
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to baseline laryngoscopy in the sniffing position
(p< 0.0001). The mean TRI was 36.23 þ/ 14.41s in
Group A while Group B had a mean TRI of 44.33 þ/
11.53s (p< 0.0001). There were no differences in both
groups with regards to secondary outcomes. A post-hoc
analysis in patients with baseline Cormack-Lehane 3 grad-
ing found a trend for improved laryngeal exposure in
Group B (70.5 þ/ 29.7%) compared to Group A (49.2
þ/ 19.6%) (p¼ 0.054).
Conclusion: In the normal population, BUHE intubation
position provides a non-inferior laryngeal view to
Glidescope intubation. The laryngeal views obtained in
both approaches were superior to the laryngeal view
obtained in the sniffing position. In addition, there is a
shorter time to intubation in the BUHE position com-
pared to Glidescope intubation. In view of the many
advantages of the BUHE position for intubation, the lack
of adverse effects, the simplicity and the cost-
effectiveness, we propose that clinicians should consider
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Hypercoagulability has been identified as a risk factor for
venous thromboembolic disease in patients undergoing
total hip arthroplasty. Whilst low molecular weight hepa-
rin (LMWH) is administered as routine postoperative
chemo-thromboprophylaxis in this group, monitoring the
effects of LMWH on global coagulation remains relatively
unexplored. Thromboelastography (TEG) is a viscoelastic
test that provides a global assessment of coagulation. We
used TEG to explore the coagulation state of total hip
arthroplasty patients receiving standard chemo-
thromboprophylaxis. We hypothesised that a hypercoagu-
lable state would be present in this patient group and
performed a prospective observational study to test
our hypothesis.
Methods: After Human Research Ethic Committee
approval and informed patient consent, we performed
this study in a University teaching hospital. We included
adult patients undergoing primary elective total hip
arthroplasty under general or spinal anaesthesia. We
excluded patients on any anticoagulation or antiplatelet
therapy and patients with any renal or hepatic impairment.
The primary objective was to assess hypercoagulability as
measured by TEG by examining changes in the maximum
amplitude from baseline values to values on postoperative
days 1, 3 and 5. Secondary outcomes included i). evaluat-
ing perioperative changes in other TEG parameters
(R-time, K-time, and alpha angle) ii). comparing perioper-
ative changes in TEG parameters in patients receiving gen-
eral anaesthesia (GA group) and spinal anaesthesia (Spinal
group), and finally iii). to assess perioperative changes in
conventional coagulation tests, namely INR, activated par-
tial thromboplastin time and fibrinogen. TEG parameters
of whole blood were assessed immediately prior to skin
incision, midpoint intraoperatively, prior to skin closure,
and for 5 days postoperatively. Conventional coagulation
tests were sampled preoperatively and on postoperative
day 5.
Results: Fifty-two patients were enrolled. 20 participants
underwent total hip arthroplasty under general anaesthe-
sia and 32 patients underwent spinal anaesthesia. All
patients received postoperative 40mg enoxaparin SC
daily. For the primary end point the median (IQR) MA
increased from baseline values of 62mm (56:68) and
61mm (54:65) in the GA and Spinal groups respectively
to 77mm (74:81) and 78mm (72:82) (p¼ 0.01) on post-
operative Day 5. Compared to baseline values the reaction
and coagulation times decreased and the a angle increased
in the middle and at the end of surgery. There were no
significant changes in the postoperative conventional coag-
ulation tests from baseline values. No patients developed
postoperative venous thromboembolism.
Discussion: Chemo-thromboprophylaxis with LMWH in
patients following elective total hip arthroplasty failed to
prevent a postoperative hypercoagulable state when
assessed by TEG. Conversely, the same chemo-
thromboprophylaxis did not demonstrate hypercoagulabil-
ity when assessed by conventional laboratory coagulation
tests. Study implications: first our findings suggest that
TEG may assist in the detection of perioperative hyper-
coagulability in patients undergoing elective total hip
arthroplasty; second, additional strategies such as the
early use of antiplatelet drugs and/or increased doses of
fractionated or unfractionated heparin may be needed in
select patients to improve the therapeutic benefit of
chemo-thromboprophylaxis after total hip arthroplasty.
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